Keiji Hirai, Susumu Ookawara, Taisuke Kitano, Haruhisa Miyazawa, Kiyonori Ito, Yuichirou Ueda, . . . Yoshiyuki Morishita. (2017). Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial. The Korean Society of Nephrology.
Chicago Style (17th ed.) CitationKeiji Hirai, et al. Efficacy and Safety of Adding Mizoribine to Standard Treatment in Patients with Immunoglobulin A Nephropathy: A Randomized Controlled Trial. The Korean Society of Nephrology, 2017.
MLA (9th ed.) CitationKeiji Hirai, et al. Efficacy and Safety of Adding Mizoribine to Standard Treatment in Patients with Immunoglobulin A Nephropathy: A Randomized Controlled Trial. The Korean Society of Nephrology, 2017.
Warning: These citations may not always be 100% accurate.